Certolizumab and anti-Certolizumab antibody

Alphabetical Test listing

Certolizumab and anti-Certolizumab antibody-15273

  
Certolizumab and anti-Certolizumab antibody
  
15273
  
LAB15273
  
CERTO
  
Anti-TNF
Anti-TNF drug
Biologic drug level and anti-drug antibody
Biologic monitoring

Cimzia
DoseASSURE
Immunogenicity testing
TDM
TNF inhibitor
  
Certolizumab drug level, anti-certolizumab antibodies and serial monitoring
  

Provides certolizumab drug concentration and anti-certolizumab antibodies in order to optimize treatment and facilitate clinical decision-making. This assay may be helpful in any patient on certolizumab therapy for Crohn's disease, psoriasis, or other autoimmune condition.

  
Serum
  
2.0 mL
  
0.6 mL
  

Immediately following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  4. Freeze
  

Frozen (preferred) - 14 days

Refrigerated - 14 days

Ambient - 18 hours

Freeze/thaw cycles: stable x 6

  
  • Gross hemolysis
  • Gross lipemia
  
Esoterix Endocrinology (804627) via LabCorp (504627) : R-LC
  
Mo
  
8 - 15 days
  

Electrochemiluminescence Immunoassay (ECLIA); Surface Plasmon Resonance

  

An interpretive report will be provided

  
80299
82397
  
08/29/2019
  
06/25/2024
  
06/25/2024